Skip to main content
. 2011 Mar 27;4:12. doi: 10.1186/1756-8722-4-12

Table 3.

Overview of patient quality of life (QoL)

Pre-Treatment 1 Month 3 Month 6 Month 9 Month 12 Month
SF-12 PCS 50 (35.2 - 58.9) 50.9 (31.4 - 61.4) 50.5 (31.4 - 61.2) 50.6 (25.7 - 56.7) 49 (27.1 - 57.2) 49 (27.6 - 59.8)
SF-12 MCS 54.8 (37.2 - 61.3) 54.4 (41.2 - 61) 55.2 (37.3 - 63.2) 55.7 (34.5 - 61.5) 57 (47.1 - 64.7) 56.5 (38.5 - 62.6)
AUA 6.8 (1 - 21) 10.8 (3 - 20) 8.1 (1 - 21) 7.7 (1 - 23) 7.5 (2 - 26) 7.4 (0 - 22)
SHIM 17.2 (3 - 25) 16 (1 - 25) 15 (1 - 25) 15.2 (1 - 25) 15.6 (1 - 25) 14.3 (1 - 25)
EPIC Urinary 90.5 (63 - 100) 82.7 (61.1 - 100) 87.7 (53.7 - 100) 88.5 (65.8 - 100) 88.1 (68.6 - 100) 89 (60.2 - 100)
EPIC Bowel 95.7 (66.7 - 100) 91.7 (62.5 - 100) 92.6 (66.7 - 100) 94.1 (70.8 - 100) 94.1 (62.5 - 100) 94.8 (75 - 100)
EPIC Sexual 66.7 (27.8 - 95.8) 66.4 (20.8 - 100) 59.9 (0 - 100) 59.8 (0 - 100) 60 (16.7 - 100) 60.1 (13.8 - 100)
EPIC Hormonal 94.2 (75 - 100) 90.9 (70 - 100) 90.8 (60 - 100) 92.3 (60 - 100) 93.6 (60 - 100) 92.1 (60 - 100)

The table shows unadjusted changes in mean toxicity and QOL scores over time. SF-12 scores range from 0 - 100 with higher values representing improved health status. AUA scores range from 0 - 35 with higher values representing worsening urinary symptoms. SHIM scores range from 0 - 25 with lower values representing worsening sexual function. EPIC scores range from 0 - 100 with higher values representing a more favorable health-related QOL. Bolded items signify a statistically significant change in reported QoL from baseline measured by Wilcoxon rank sum test at 0.05 significance level.